K2 HealthVentures logo

K2 HealthVentures

North America, Massachusetts, United States, Boston

Description

K2 HealthVentures is an alternative investment firm.

Investor Profile

K2 HealthVentures has made 15 investments, with 4 in the past 12 months and 20% as lead.

Stage Focus

  • Series C (20%)
  • Series B (20%)
  • Post Ipo Debt (13%)
  • Post Ipo Equity (13%)
  • Debt Financing (13%)
  • Series Unknown (13%)
  • Series E (7%)

Country Focus

  • United States (93%)
  • Singapore (7%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Home Health Care
  • Pharmaceutical
  • Elder Care
  • Mhealth
  • Consulting
  • Business Development
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does K2 HealthVentures frequently co-invest with?

Rubicon Founders
North America, Tennessee, United States, Nashville
Co-Investments: 2
CA
North America, Massachusetts, United States, Boston
Co-Investments: 2
New Leaf Venture Partners
North America, New York, United States, New York
Co-Investments: 2
Valtruis
North America, New York, United States, New York
Co-Investments: 2
Oak HC/FT
North America, Connecticut, United States, Greenwich
Co-Investments: 4
8VC
North America, California, United States, San Francisco
Co-Investments: 1
aMoon Fund
Asia, HaMerkaz, Israel, Ra'anana
Co-Investments: 1
Revelation Partners
North America, California, United States, San Francisco
Co-Investments: 2
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 1
Invus
North America, New York, United States, New York
Co-Investments: 2

What are some of recent deals done by K2 HealthVentures?

Umoja Biopharma

Seattle, Washington, United States

Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.

BiopharmaBiotechnologyDeveloper Platform
Series CJan 14, 2025
Amount Raised: $100,000,000
Evergreen Nephrology

Nashville, Tennessee, United States

Evergreen helps nephrologists focus on the right patients at the right time across the full care spectrum.

Health CareMedicalWellness
Series UnknownJan 7, 2025
Amount Raised: $130,000,000
HarmonyCares

Troy, Michigan, United States

HarmonyCares is a home-based health care provider for adults and for those with complex medical issues.

Assisted LivingElder CareHealth CareHome Health CareNursing and Residential Care
Series UnknownJul 8, 2024
Amount Raised: $200,000,000
Hopscotch Primary Care

Chicago, Illinois, United States

Hopscotch Primary Care is a healthcare company that aims to transform healthcare for rural communities across the country.

ConsultingHealth CareMedical
Series CJun 28, 2024
Amount Raised: $50,000,000
Harpoon Therapeutics

South San Francisco, California, United States

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityOct 23, 2023
Amount Raised: $100,000,000
Vedanta Biosciences

Cambridge, Massachusetts, United States

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

BiotechnologyBusiness DevelopmentMedical
Series EApr 25, 2023
Amount Raised: $106,500,000
Harpoon Therapeutics

South San Francisco, California, United States

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityMar 27, 2023
Amount Raised: $25,000,000
DispatchHealth

Denver, Colorado, United States

DispatchHealth is a mobile and virtual healthcare that provides virtual medicine, modern house call, and health information technology.

Health CareHome Health CareInsurTechMedicalmHealth
Debt FinancingNov 15, 2022
Platelet BioGenesis

Watertown, Massachusetts, United States

Platelet Biogenesis is an allogeneic cell therapy company that focuses on platelet biology.

BiotechnologyEdiscoveryLife ScienceProduct Research
Series BNov 4, 2021
Amount Raised: $75,500,000
Click Therapeutics

New York, New York, United States

Click Therapeutics delivers safe and effective digital treatments to patients in need.

BiotechnologyHealth CareMedical DevicePharmaceuticalTherapeutics
Series BOct 22, 2021
Amount Raised: $52,000,000